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With the explosion of genome-wide studies of regulated transcription, it has become clear that
traditional definitions of enhancers and promoters need to be revisited. These control elements
can now be characterized in terms of their local and regional architecture, their regulatory compo-
nents, including histone modifications and associated binding factors, and their functional contri-
bution to transcription. This Review discusses unifying themes between promoters and enhancers
in transcriptional regulatory mechanisms.Recent genome-wide studies have significantly advanced our
understanding of the genomic architecture that underlies gene
expression in higher eukaryotes. Integrative analyses of the tran-
scriptome, transcription factor (TF) binding profiles, and epige-
nomes reveal complex organization of individual transcription
units scattered throughout the genome and causal relationships
among the regulatory DNA sequences, chromatin state, and
transcriptional activity. In particular, a considerable amount of
data have established that enhancers are not merely a collection
of TF binding sites, but also have the capacity to drive transcrip-
tion independent of their target promoters. This feature of en-
hancers suggests that they serve more regulatory functions
than previously appreciated.
Regulatory DNA Elements in Eukaryotic Gene
Expression
Transcription of a gene in eukaryotes is a highly complex
process that requires precise coordination in the assembly of
trans-acting factors through the recognition of various types
of regulatory DNA sequences. The promoter and the enhancer
represent DNA regulatory regions responsible for ensuring
proper spatiotemporal expression patterns of eukaryotic
genes. The promoter generally refers to a DNA region that
allows accurate transcription initiation of a gene (Smale and
Kadonaga, 2003). The core promoter is a minimal stretch of
DNA sequences (e.g., the TATA box, initiator, and downstream
core promoter element) surrounding the transcription start
site that directly interacts with the components of basal tran-
scription machinery, including RNA polymerase II (RNAPII).
Although the DNA sequences or motifs comprising the core
promoter region for individual genes can be structurally and
functionally diverse, its universal role is thought to drive accu-
rate transcription initiation (Smale and Kadonaga, 2003). Tran-
scription factors that bind 100–200 bp upstream of the core
promoter can increase the rate of transcription by facilitating
the recruitment or assembly of the basal transcription machin-
ery onto the core promoter or by mediating the recruitment of948 Cell 162, August 27, 2015 ª2015 Elsevier Inc.specific distal regulatory DNA sequences to the core promoter
(Akbari et al., 2008).
These distal sequences, known as enhancers, activate or in-
crease the rate of transcription from the target gene promoter
independent of their position and orientation with respect to
target genes (Maniatis et al., 1987). In multicellular organisms,
enhancers are primarily responsible for the precise control of
spatiotemporal patterns of gene expression. Enhancer elements
were initially discovered in the early 1980s in studies that charac-
terized eukaryotic gene promoters. Functional tests of sea urchin
histone gene expression in the Xenopus oocyte identified DNA
sequences located upstream of the TATA box motif that
positively influence H2A gene transcription, originally termed
transcriptional ‘‘modulators’’ (Grosschedl and Birnstiel, 1980).
Deletion of the modulator resulted in 15- to 20-fold decrease in
H2A gene expression. Interestingly, the modulator activity was
retained even when its DNA sequence was inverted. Similarly,
the tandem 72 bp DNA repeats located upstream of viral SV40
early gene were found to be indispensable for SV40 early gene
expression (Benoist and Chambon, 1981). Shortly after those
initial observations, a series of studies on the SV40 enhancer es-
tablished the conceptual framework for defining enhancers as
follows (Atchison, 1988; Banerji et al., 1981; Fromm and Berg,
1982, 1983; Khoury andGruss, 1983;Moreau et al., 1981): (1) En-
hancers increase transcription of a linked gene from its correct
initiation site specified by the core promoter, (2) enhancer activity
is independent of orientation relative to its target gene, (3) en-
hancers can function independent of their position relative to
the target genes, and also over long distances, (4) enhancers
can function with a heterologous promoter, (5) enhancers exhibit
DNase I hypersensitivity (HS), which reflects a less compacted
chromatin state as a result of the binding of various transcription
factors. Although these properties were defined more than three
decades ago, they are still widely used to classify enhancers.
Subsequent studies identified the first mammalian cellular
enhancer, which is required for efficient expression of the immu-
noglobulin (Ig) heavy-chain gene (Banerji et al., 1983; Gillies
et al., 1983; Neuberger, 1983). Importantly, the Ig enhancer
studies provided the first evidence demonstrating that enhancer
activity exhibits tissue or cell-type specificity. When various cell
lines were tested, Ig enhancer activity was observed only in
lymphocyte-derived cell lines (Banerji et al., 1983; Gillies et al.,
1983). Since then, a variety of cell-type- or developmental
stage-specific enhancers have been determined to regulate the
expression of genes in higher organisms (Mu¨ller et al., 1988).
Transcriptional activation of yeast genes was also shown to be
mediated by enhancer-like sequences, known as upstream acti-
vation sequences (UASs), although their distances from the core
promoters are much shorter (within a few hundred base pairs)
than the typical distances between enhancers and promoters in
mammals (Guarente, 1988). These results led to the realization
that enhancer activity is the primary mechanism for determining
the spatiotemporal gene expression pattern in eukaryotes.
RNAPII Association at Enhancers and Locus Control
Regions
The ability to recruit RNAPII and initiate transcription has gener-
ally been considered the most unique property of promoters.
However, even before the genomics era, several studies found
that RNAPII can be directly recruited to enhancers upon tran-
scriptional induction, potentially serving as a regulatory check-
point for RNAPII delivery to the target promoter. Interestingly,
an early study of the SV40 enhancer found that, in the absence
of any known promoter sequence, the 72 bp DNA repeats can
also ‘‘promote’’ gene expression, although this was deemed to
be inefficient (Benoist and Chambon, 1981; Moreau et al.,
1981). This finding suggested the possibility that the 72 bp
sequence might serve as a general entry site for a component
of the transcription machinery, such as RNAPII, which could
then track along the DNA to a transcription initiation site (Moreau
et al., 1981). Another proposed mechanism that may not be
mutually exclusive with the RNAPII tracking model is the chro-
matin remodeling effect. As various chromatin modifying
enzymes such as histone acetyltransferases and methyltrans-
ferases can be part of the RNAPII transcription complex (Cho
et al., 1998; Gerber and Shilatifard, 2003), transcription initiated
from the enhancer proceeding across the intervening regions
between the enhancer and the target promoter might be respon-
sible for establishment and/or maintenance of an active chro-
matin conformation required for efficient gene transcription.
Initial studies of enhancer identification and characterization
were carried out by transient transfection experiments, which
means that enhancer activity may be subject to position-effect
variegation, depending on the chromatin configuration at the
genomic site of integration. However, a study of a transgene
containing the human b-globin locus discovered that five
DNase-I-hypersensitive sites scattered in a 70 kb region sur-
rounding the b-globin gene were sufficient to overcome the
positional effect (Grosveld et al., 1987). These cis-regulatory re-
gions (e.g., enhancers) conferring activation of a linked gene in a
tissue-specific, copy-number-dependent manner, independent
of its position of integration, were collectively termed a locus
control region (LCR) (Orkin, 1990). Notably, transcription activity
was detected at enhancers located within the b-globin LCR re-
gion and throughout the intervening DNA into the globin genes(Ashe et al., 1997; Routledge and Proudfoot, 2002; Tuan et al.,
1992). These LCR-driven intergenic transcripts are relatively
short (< 3 kb), remain in discrete foci in the nucleus, and do not
encode proteins (Ling et al., 2005). Transcription predominantly
occurred toward the downstream globin genes but was indepen-
dent of the orientation, position, and distance of the enhancers
with respect to the gene (Kong et al., 1997; Routledge and
Proudfoot, 2002). RNAPII recruitment and transcription activity
have also been observed in other LCRs, including those that
control expression of major histocompatibility complex (MHC)
class II in antigen-presenting immune cells and pituitary-specific
expression of the human growth hormone (hGH) gene (Ho et al.,
2006; Masternak et al., 2003). Interestingly, insertion of an exog-
enous RNAPII termination sequence within the hGH-LCR
blocked hGH regulation, suggesting that transcription through
the LCR domain is a functionally important event.
In both the human andmurine b-globin gene loci, RNAPII inter-
acts with the LCR, but not directly with the b-globin gene prior to
erythroid differentiation, whereas it is associated with both in
differentiated erythroid cells (Levings et al., 2006; Vieira et al.,
2004). In an in vitro assay using nuclear extracts from MEL cells,
RNAPII and other basal transcription factors associated with im-
mobilized LCR templates could be transferred to a b-globin gene
template, whichwas facilitated by the erythroid transcription fac-
tor NF-E2 (Vieira et al., 2004). Although performed in vitro, these
results suggest a model in which the b-globin LCR functions to
assemble and hold the RNAPII transcription complex for timely
delivery to the b-globin gene to ensure the developmentally
stage-specific expression. Furthermore, blocking transcription
elongation between the LCR and the promoter by inserting a
transcription terminator sequence significantly decreased the
b-globinmRNA level, suggesting that the b-globin LCR facilitates
a tracking and transcription mechanism (Ling et al., 2004). A
similar mechanism has been proposed for other LCRs and
enhancers (Ho et al., 2006; Wang et al., 2005). In a contrasting
model, transfer of the RNAPII machinery from the a-globin LCR
to the promoter appears to be mediated by formation of a DNA
loop between the LCR and the promoter, as no RNAPII signal
is detected in the intervening DNA between the LCR and the pro-
moter (Vernimmen et al., 2007).
Genome-wide Architecture of Enhancers
These initial insights into the complex roles of enhancers and
LCRs set the stage for thinking about regulatory elements in
a more global manner. Early genome-wide studies identified
RNAPII binding at intergenic loci, which suggested the existence
of enhancer-like sequences across the genome; however, there
were questions regarding the functional relevance of such
RNAPII occupancy (Barrera et al., 2008; Brodsky et al., 2005;
Carroll et al., 2006; Heintzman et al., 2007). Moreover, it was
difficult to classify RNAPII binding sites as possible enhancer
or un-annotated promoter of a protein-coding gene by the virtue
of RNAPII association alone.
It became clear that additional criteria would be needed to
identify enhancers. Given their association with transcription fac-
tors, computational analysis of TF binding motifs combined with
the assessment of evolutionary conservation within the DNAwas
used as a popular approach in identifying enhancers (reviewed inCell 162, August 27, 2015 ª2015 Elsevier Inc. 949
Aerts, 2012). More recently, chromatin-immunoprecipitation-
based analysis of TF binding in vivo (e.g., ChIP-chip and ChIP-
seq) has been widely used to experimentally determine actual
TF binding sites in vivo. This approach revealed that only a small
fraction of TF bindingmotifs are actually bound by TFs in vivo in a
given tissue and/or stage (ENCODE Project Consortium et al.,
2007). TF binding per se does not signal a functional outcome.
Functional activation requires recruitment of additional cofactors
or mechanisms involving a combinatorial coordination of multi-
ple TFs. Therefore, analysis of evolutionarily conserved TFmotifs
or TF binding alone has a limited power for identification and
prediction of functional enhancers (see also Kellis et al., 2014
for review).
Transcriptional coactivators p300 and CBP interact with a
large number of transcriptional activators and the general tran-
scription machinery, including RNAPII. Moreover, both p300
and CBPdisplay acetyltransferase activity toward the tails of his-
tones localized near cis-regulatory regions, which is thought to
create a transcriptionally permissive chromatin structure. There-
fore, although not perfect, genome-wide analysis of p300/CBP
binding sites has been commonly used as a method for identi-
fying enhancer elements in vivo without having to investigate
individual TFs (May et al., 2012; Visel et al., 2009)
A complementary approach in identifying enhancers takes
advantage of their chromatin accessibility. The assembly of
various TF complexes at cis-regulatory regions is considered
to compete with stable association of nucleosomes. As a result,
active enhancers and promoters have reduced nucleosome
density and display hypersensitivity to DNase I digestion. This
feature of chromatin accessibility has been utilized in next-gen-
eration sequencing-based techniques such DNase-seq, FAIRE-
seq, and ATAC-seq (Boyle et al., 2008; Buenrostro et al., 2013;
Giresi et al., 2007) to identify enhancers without any prior
knowledge of TF binding motifs or TF binding. Although not
sufficient to pinpoint cell-type-specific enhancers due to its
indiscriminate nature, this method can be very useful for
enhancer characterization when combined with other mapping
techniques.
An increasing number of epigenomic studies have illustrated
that the chromatin of metazoan genomes is organized into
modular domains that represent unique chromatin states formed
by a combination of multiple post-translational modifications on
histones within the nucleosomes (ENCODE Project Consortium,
2012; Ernst et al., 2011). For example, nucleosomes within
enhancer regions contain histone variants H3.3 and H2A.Z
(Goldberg et al., 2010; Henikoff et al., 2009; Jin et al., 2009).
These nucleosome variants are deposited into enhancer regions
in a replication-independent manner and are more sensitive to
high salt than canonical nucleosomes. In contrast, nucleosomes
flanking TF-bound sites are stable and undergo various histone
modifications that are distinctive to each functional domain
and across cell types and also correlate with transcriptional out-
puts (ENCODE Project Consortium, 2012; Heintzman et al.,
2007, 2009; Hon et al., 2009; Visel et al., 2009). Importantly,
such chromatin modifications combined with other measures
(chromatin accessibility and TF binding) have proven themselves
a useful barometer for active enhancers. Enhancers of active
genes generally display a high level of mono- or di-methylation950 Cell 162, August 27, 2015 ª2015 Elsevier Inc.on H3 lysine 4 (H3K4me1/2) but are low or devoid of
H3K4me3, whereas promoter sequences show the opposite
pattern. In addition to H3K4me1/2, mutually exclusive modifica-
tions on H3K27 residues co-segregate with active or inactive/
poised enhancers (Creyghton et al., 2010; Rada-Iglesias et al.,
2011). Active enhancers are enriched in the H3K27ac mark, a
major substrate for the histone acetyltransferase p300/CBP
(Jin et al., 2011; Tie et al., 2009), while poised enhancers are
associated with H3K27me3, a mark enriched in Polycomb
(PcG)-associated and transcriptionally repressed regions
(Rada-Iglesias et al., 2011). Additionally, H3K27me3 also co-
exists with the active promoter mark H3K4me3 in the promoters
of developmentally silenced genes in ES cells, known as poised/
bivalent promoters (Bernstein et al., 2006).
Although enhancers share common structural and functional
features, as described above, individual enhancers widely differ
in the enrichment levels of TF- and enhancer-specific histone
modifications. A set of recent studies inspected enhancers
based on the quantitative difference in the level of Mediator com-
plex binding or H3K27ac marks and found that enhancers are
often clustered in large domains, termed super-enhancers. Typi-
cally a few hundred super-enhancers are present in a given cell
type and are often located near cell-type-specific genes or the
genes that control the biological processes that define the iden-
tities of the cell types (Hnisz et al., 2013; Love´n et al., 2013;
Whyte et al., 2013). Consistently, a strong enrichment of dis-
ease-associated non-coding variants has been observed within
super-enhancers (Hnisz et al., 2013). Each super-enhancer rep-
resents a functional cluster of multiple enhancer units that
communicate with each other physically and functionally and
provide a platform where various signaling pathways converge
to robustly regulate genes that control cell identity during devel-
opment and tumorigenesis (Hnisz et al., 2015). With that opera-
tional definition, super-enhancers appear to be highly analogous
to the ‘‘regulatory archipelago’’ described at the HoxD locus
(Montavon et al., 2011). Although more analysis will be required
to establish whether or not super-enhancers reflect a novel para-
digm in gene regulation, their identification in each cell type
would, at least, be very useful for the characterization of the
cell-type-specific regulatory network.
From Enhancer Sequences to Enhancer RNAs
In 2010, two independent studies reported that direct RNAPII
recruitment and transcription are genome-wide features of func-
tionally active enhancers. In neurons, a combination of enhancer
markers (high levels of H3K4me1 overlapped with CBP binding
but with no or low H3K4me3) was used to identify 12,000
neuronal enhancers that mediate transcription induction upon
neuronal activation by membrane depolarization (Kim et al.,
2010). Interestingly 25% of the neuronal enhancers also ex-
hibited a significant level of RNAPII binding and produced RNA
transcripts. These enhancer RNAs (eRNAs) are dynamically
regulated by neural activity, with their levels positively correlating
with mRNA levels of nearby protein-coding genes. The majority
of eRNAs characterized in neurons are short (<2 kb), lack polya-
denylated tails, and do not appear to be spliced. Notably, global
profiling showed that eRNAs are transcribed bi-directionally
from the center of enhancers, where CBP andRNAPII are bound.
Figure 1. A Contemporary View on Pro-
moters and Enhancers
Features of promoters include transcription initia-
tion in the sense and anti-sense direction being
mediated by the transcription machinery assem-
bled independently onto its own core promoter.
Although not shown here, convergent transcription
has been observed at the promoters of weakly
expressed genes. H3K4me3 is highly enriched
at the promoter regions. Enhancer-like chromatin
signatures (H3K4me1 and H3K27ac) and the Tyr-
1P form of RNAPII have also been observed near
the upstream anti-sense TSSs. Polyadenylation
sites are enriched near the 30 end of the upstream
anti-sense RNAs and mediate the exosome-
dependent degradation of the antisense RNAs. 50
splice sites are only present in the coding gene and
might contribute to the productive elongation of
sensemRNA transcripts through the binding of the
U1 splicing complex, which blocks PAS-mediated
early termination. The Ser-5P form of RNAPII is
engaged in upstream anti-sense transcription, but
it is not known whether Ser-2P of RNAPII occurs
during the elongation of anti-sense RNA.
Features of enhancers include, as with the pro-
moter, recruitment of the general transcription
factors (GTF), including RNAPII, and initiation of
transcription at defined sites. Enhancer-driven
transcription typically exhibits more prominent
bi-directionality than that stemming from the
promoter. H3K4me1/2 is commonly enriched at enhancers. Functionally active enhancers also exhibit a high level of H3K27 acetylation, whereas poised or
inactive enhancers are marked by H3K27me3. Ser-5P and Tyr-1P forms of the RNAPII have been observed. It is not clear whether or not Ser-2P RNAPII and
H3K36me3 marks are present at active enhancers. 50 splice site sequences are not enriched near the regions surrounding enhancers. Both strands of enhancer
RNAs appear to be degraded by the exosome, although it is not known whether it is mediated by the PAS-dependent mechanism.Another study discovered eRNAs (originally referred to in the
study as inducible upstream extragenic transcripts) in endo-
toxin-stimulated primary macrophages (De Santa et al., 2010).
RNAPII ChIP-seq analysis identified 4,855 extragenic RNAPII
binding sites, and 70% of them showed an enhancer-like
chromatin signature (high levels of H3K4me1 with low or no
H3K4me3). Many of these extragenic enhancers produce eRNAs
upon LPS stimulation. Unlike neuronal eRNAs, several macro-
phage eRNAs were shown to be produced from uni-directional
transcription and to be polyadenylated without being spliced.
Since these initial discoveries, eRNAs have been found in
many mammalian cell types, including embryonic stem cells,
suggesting that eRNA synthesis is a universal cellular mecha-
nism (reviewed in Lam et al., 2014). Super-enhancers exhibit a
much higher level of RNAPII binding and eRNA transcription
than typical enhancers (Hah et al., 2015; Hnisz et al., 2013). Mul-
tiple eRNAs are generatedwithin super-enhancers with a striking
correlation in their expression patterns, which could imply that
each super-enhancer might form a single regulatory module
(Hah et al., 2015). Importantly, a recent study has identified the
RNAPII-associated complex, Integrator, as the molecular ma-
chine involved in the 30 end processing of eRNAs at enhancers
and super-enhancers (Lai et al., 2015).
As greater numbers of eRNAs have been identified, we’ve
gained more detailed insights into their properties and regula-
tion. The majority, although not all, of eRNAs in the nucleus
lack polyadenylated tails (ENCODE Project Consortium, 2012;
Derrien et al., 2012; Djebali et al., 2012; Harrow et al., 2012).
A genome-wide study in murine CD4+ CD8+ thymocytes
correlated non-polyadenylated and polyadenylated eRNAswith bi-directional and uni-directional transcription, respectively,
although the functional implication of this dichotomy is not
known (Koch et al., 2011; Natoli and Andrau, 2012). Moreover,
eRNA-producing enhancers are cell-type specific and are
associated with a chromatin signature unique to functionally
active enhancers, including H3K4me1, H3K27 acetylation, and
H3K79 dimethylation, along with RNAPII binding (Djebali et al.,
2012). A genome-wide chromosomal interaction study in several
human cell lines further demonstrated that eRNA-producing
enhancers are preferentially engaged in an interaction with the
proximal promoters (Sanyal et al., 2012). Another notable feature
of eRNAs is the timing of their expression relative to mRNA
upon stimulus-dependent induction. In many different cell types,
eRNA transcription marks the earliest response in the wave of
transcriptional change when cells undergo a state change in
response to environmental or developmental cues (Arner et al.,
2015; De Santa et al., 2010; Hah et al., 2013; Hsieh et al.,
2014; Schaukowitch et al., 2014).
Promoter versus Enhancer: A New Comparison in the
Genomic Era
Recent genome-wide evidence of transcribing enhancers
observed in a wide range of cell types argues that the conven-
tional definitions of the promoter and the enhancer must be
revised. The roles of promoters and enhancers in transcription
have been thought to be distinct; however, these two regulatory
elements are highly interrelated and show noticeable similarities
in structure and function. As summarized below, both the pro-
moter and theenhancer exhibit commonstructural and functional
features that have not been previously appreciated (Figure 1).Cell 162, August 27, 2015 ª2015 Elsevier Inc. 951
Shared Local Structure
Both promoters and enhancers display DNase I hypersensitivity,
which results from depletion of nucleosomes. This local struc-
ture arises because both regulatory regions are composed of
binding sites for TFs, which exclude nucleosomes. However,
whether or not there is any distinguishable difference in TF bind-
ing site composition between the regions is somewhat debat-
able. Initial genome-wide studies suggested that promoters
and enhancers differ in the composition of binding sites (Rada-
Iglesias et al., 2011; Shen et al., 2012; Thurman et al., 2012).
However, recent FANTOM5 cap analysis gene expression
(CAGE) studies argue that the difference in binding site compo-
sition might simply result from the fact that enhancers are largely
devoid of CpG islands (CGI) and repeats resembling non-CGI
promoters (Andersson et al., 2014). Consistently, some older
studies showed that interacting promoter-enhancer pairs often
harbor common TF binding sites (Bienz and Pelham, 1986; Boh-
mann et al., 1987; Parslow et al., 1987).
Consistent Histone Modification Patterns
Although the local ratio of H3K4me3/me1 has been widely
used as ameans to distinguish enhancers and promoters, recent
studies argue that the three H3K4methylation states (H3K4me1/
2/3) simply reflect dynamic changes in transcription activities
of both the promoters and enhancers rather than representing
static and intrinsic features of individual regulatory elements.
The majority of enhancers simply show a low H3K4me3/me1 ra-
tio, as their transcription level is generally lower than promoter-
driven transcription. However, H3K4me3 is often observed at
functionally active enhancers, and the H3K4me3/me1 ratio posi-
tively correlates with transcription level, independent of tran-
script stability (Core et al., 2014; Koch et al., 2011; Pekowska
et al., 2011).
Functional Interchangeability
The notion that promoters and enhancers functionally overlap
was initially supported by the finding that the proximal promoter
region of mouse metallothionein I (Mt1) gene, when inserted
downstream of a rabbit b-globin test gene, could enhance
b-globin transcription upon metal ion stimulation, thus acting
as an inducible enhancer (Serfling et al., 1985). Moreover,
a chromosomal interaction study found that promoters
frequently associate with other promoters through space analo-
gous to well-characterized promoter-enhancer interactions,
which could imply an enhancer-like function of the promoter
in transcription (Li et al., 2012). Recently, intragenic enhancers
were shown to frequently function as alternative tissue-specific
promoters, producing a class of abundant, spliced, multi-exonic
poly(A)+ RNAs (meRNAs) reflecting the host gene’s structure
(Kowalczyk et al., 2012). These examples collectively support
the notion that the enhancers and promoters not only share
many of the similar architectural features (nucleosome hyper-
sensitivity and chromatin marks), but also may be functionally
interchangeable.
Common Mechanisms to Control RNA Synthesis
Similar to promoters, RNAPII and general transcription factors
(GTFs) are assembled on enhancers and initiate transcription
(Koch et al., 2011; Natoli and Andrau, 2012). The C-terminal
domain (CTD) of RNAPII is composed of multiple heptapeptide
repeats (YSPTSPS) and undergoes differential phosphorylation952 Cell 162, August 27, 2015 ª2015 Elsevier Inc.as the transcription cycle progresses. While unphosphorylated
RNAPII enters the pre-initiation complex, escape from the pro-
moter is highlighted by phosphorylation of the Ser-5 residues
of the CTD, and entry of the RNAPII into productive elongation
is coordinated by a wave of Ser-2 phosphorylation. Both un-
phosphorylated and Ser-5-phosphorylated forms of RNAPII are
also observed at enhancers. Moreover, tyrosine 1 phosphoryla-
tion of the RNAPII CTD has been observed with antisense pro-
moter transcription and active enhancers in mammalian cells
(Descostes et al., 2014). However, the elongation-specific form
of RNAPII (Ser-2-phosphorylated), as well as the H3K36me3
mark, both of which are normally seen across the coding regions
of actively transcribing genes, have not been readily detected
in the eRNA transcribing areas (Kaikkonen et al., 2013; Koch
et al., 2011; Natoli and Andrau, 2012). On the other hand,
several studies observed H3K79me2/3 marks over transcribed
enhancer regions, an additional coding-region-specific modifi-
cation whose levels are highly correlated with transcription activ-
ity (Bonn et al., 2012; Djebali et al., 2012).
At this point, it is not clear whether the lack of elongation-spe-
cific marks (H3K36me3 and Ser-2 phosphorylation of RNAPII) at
enhancers reflect a fundamentally different transcription mecha-
nism between enhancers and promoters or whether the eRNA
regions being transcribed are simply not long enough to suffi-
ciently accumulate thosemarks, which are known to be enriched
near the 30 end of genes. Alternatively, the levels of eRNA tran-
scription might not be high enough to observe the enrichment
of these elongation-specific features, as their levels are generally
correlated with transcription output.
Bi-Directional Transcription
Bi-directionality is a striking feature of eRNA transcription that
has been documented at many enhancers. However, the major-
ity of mammalian promoters also drive divergent transcription,
resulting in the production of short antisense ncRNAs (known
as uaRNAs, PROMPTs, or promoter upstream transcripts) from
upstream promoter regions in addition to sense mRNAs (Core
et al., 2008; Preker et al., 2008; Seila et al., 2008). Both eRNAs
and promoter upstream antisense transcripts are relatively un-
stable, possibly due to exosome-mediated degradation (Ander-
sson et al., 2014; Flynn et al., 2011). Genome-wide analyses
integrating nascent transcript mapping, DNase I hypersensitive
sites, nucleosome positions, and binding profiles of various
TFs and histone modifications have corroborated the shared
architecture of transcription initiation between enhancers and
promoters. Both enhancers and promoters exhibit similar fre-
quencies of canonical core promoter elements, highly positioned
flanking nucleosomes, and tight average spacing (110 bp) be-
tween each pair of divergent TSSs. Divergent transcription at
promoters and enhancers is mediated by independent RNAPII
transcription complexes assembled at each TSSs, which is
intrinsically configured by underlying core elements as well as
TF binding motifs enriched near both sense and anti-sense
TSSs (Core et al., 2014; Duttke et al., 2015; Scruggs et al.,
2015). Moreover, elevated levels of TF binding and enhancer-
like chromatin signatures (e.g., high levels of H3K4me1 and
H3K27ac) were observed near the anti-sense TSSs located
upstream of highly transcribed sense TSSs (Scruggs et al.,
2015). Intriguingly, a nucleotide-resolution mapping analysis of
RNAPII position by native elongating transcript sequencing
(NET-seq) has revealed that the promoters of genes expressed
at a low level in human HeLa or HEK293T cells drive convergent
transcription, in which antisense transcription originates down-
stream of the sense TSS (Mayer et al., 2015). It is not known
whether convergent transcription is also a feature of enhancers.
Regulation of Upstream Transcription
Computational analysis of promoters showed that the regions
where upstream antisense transcription occurs are enriched in
polyadenylation sites (PAS) but are depleted of potential U1
small nuclear ribonucleoprotein (snRNP) recognition sites, or 50
splice site-like sequences. This asymmetric feature in functional
DNA motifs flanking TSSs was argued to underlie promoter
directionality (Almada et al., 2013; Core et al., 2014; Ntini et al.,
2013). Transcription of upstream antisense RNAs terminates
at the enriched PAS, and the RNAs are then degraded by the
exosome, whereas the sense transcripts are protected by U1
snRNP, which prevents premature cleavage and polyadenyla-
tion (Berg et al., 2012; Kaida et al., 2010). The FANTOM5
CAGE analysis suggested that the eRNAs are also subject to a
similar decay mechanism. However, unlike the promoters, the
DNA regions flanking enhancers do not show an enrichment of
50 splice site sequences (Andersson et al., 2014).
The Role of Enhancer Transcription
The defined characteristics of eRNAs—low abundance, low sta-
bility, lack of RNA processing such as polyadenylation and
splicing, and bi-directionality in transcription—could collectively
suggest that eRNAs are the byproduct of enhancer transcription
activity, with no biological function. This idea of transcriptional
noise proposes that excess RNAPII machinery is uniformly asso-
ciated with physically accessible genomic regions, including
enhancer regions, and initiates transcription ‘‘nonspecifically’’
from incorrect sites (Struhl, 2007). In this model, nonspecific
transcripts are generally in low abundance, as they are rapidly
degraded by intrinsic cellular surveillance mechanisms such as
nonsense-mediated decay or exosome-mediated degradation
(LaCava et al., 2005; Wyers et al., 2005).
However, transcription does not appear to be a random pro-
cess. For example, there is no transcription activity in poised en-
hancers, which clearly show chromatin accessibility judged by
DNase I hypersensitivity. It was also proposed that enhancers
that mediate rapid induction of neural genes in response to
membrane depolarization do not transcribe eRNAs unless the
enhancer is paired with its target promoter (Kim et al., 2010).
However, enhancer transcription initiated from hGH-LCR in the
pituitary was independent of the interaction with the target
hGH-N promoter (Yoo et al., 2012). Despite this discrepancy in
the promoter dependency of eRNA production, it is generally
agreed that eRNA transcription occurs only from functionally
active enhancers in a regulated manner (Andersson et al.,
2014; Core et al., 2014; Creyghton et al., 2010; Hah et al.,
2011; Kaikkonen et al., 2013; Kim et al., 2010; Rada-Iglesias
et al., 2011). Furthermore, as we have described, both en-
hancers and promoters share key architectures of transcriptional
initiation sites. These features collectively suggest that eRNA
synthesis is a regulated process, with its transcription initiation
fidelity comparable to the promoter, rather than a consequenceof random RNAPII transcription initiation from accessible
genomic regions. However, they do not necessarily prove
the functionality of eRNA transcripts (Weingarten-Gabbay and
Segal, 2014).
When considering the functional relevance of enhancer
transcription, several lines of evidence suggest that the act of
eRNA transcription, rather than the eRNA transcript itself, might
have a specific biological function. One possibility is that
enhancer-promoter pairing or looping is mediated by a tracking
mechanism in which the enhancer-bound transcription com-
plex is ferried to a specific target promoter via uni-directional
RNAPII transcription. Consistently, LCR-driven transcription
takes a uni-directional path toward target genes (Ashe et al.,
1997; Ho et al., 2006; Ling et al., 2005; Routledge and Proud-
foot, 2002), and some eRNAs in T lymphocytes were also
shown to be transcribed uni-directionally (Koch et al., 2011;
Natoli and Andrau, 2012). However, global profiles of eRNA
expression argue that such a simple tracking/scanning mecha-
nism of enhancer-promoter communication might not be
general, as the majority of enhancer transcription occurs bi-
directionally within confined flanking regions not contiguous
to the target gene.
Since RNAPII can carry histone-modifying enzymes through
interactions with its CTD (see review in Selth et al., 2010),
RNAPII transcription could be an underlying mechanism for
altering the chromatin architecture at enhancers or intervening
DNA regions between enhancers and promoters. Indeed, active
chromatin modifications such as histone hyperacetylation and
DNase I hypersensitivity are often observed near RNAPII-tran-
scribed regions (Bulger et al., 2003; Gribnau et al., 2000; Mas-
ternak et al., 2003; Travers, 1999). For example, a transcription
inhibitor, actinomycin D, significantly blocked LPS-induced his-
tone hyperacetylation in the intervening regions between induc-
ible gene promoters and enhancers in macrophages (De Santa
et al., 2010). Another study in macrophages showed that TLR4-
signaling-induced eRNA transcription precedes a local increase
in the level of H3K4me1/2, and the length of eRNAs coincides
with the width of the H3K4me1/2-modified region (Kaikkonen
et al., 2013). A transcription elongation inhibitor, flavopiridol,
but not eRNA knockdown, significantly reduces the level of
H3K4me1/2 at enhancers, suggesting that transcription activity
at enhancers, not the eRNA transcript itself, might be important
for at least some aspect of enhancer-specific chromatin modi-
fication (Kaikkonen et al., 2013). However, flavopiridol treatment
in MCF-7 cells did not alter the levels of enhancer-specific
histone marks (i.e., H3K4me1 or H3K27ac) (Hah et al., 2013).
One potential source for this discrepancy might be differences
in the stability of the enhancer-specific marks between the
two cell types (T cells versus MCF-7 cells) and/or the mode
of stimulus-induced signaling, although the aforementioned
study in macrophages claimed that the effect of transcription
blockers in H3K4me1/2 modifications is also observed in pre-
existing enhancers (Kaikkonen et al., 2013). It also needs to
be noted that the proposed function of enhancer transcription
in the enhancer-specific chromatin landscape does not have
to be mutually exclusive with the possibility that the eRNA
transcript itself might play a functional role in transcriptional
activation.Cell 162, August 27, 2015 ª2015 Elsevier Inc. 953
Figure 2. Mechanisms of Enhancer-Pro-
moter Interactions
H3K4me1/2 modification at enhancers can be
mediated by RNAPII transcription activity.
Enhancer RNA is also shown to play a role in
various stages of transcription. Looping: The
Mediator/Cohesin complex is involved in stable
formation of enhancer-promoter looping. Some
eRNAs (e.g., ncRNA-a and eRNAs expressed
from estrogen receptor-a bound enhancers) facil-
itate the looping through an interaction with the
subunit(s) of the Mediator/Cohesin complex.
Chromatin remodeling: eRNAs (e.g., CERNA) can
also promote transcription by remodeling the
chromatin structure such that the accessibility of
RNAPII machinery is increased. RNAPII transition:
Early RNAPII elongation is another transcription
step regulated by eRNAs. eRNAs (e.g.,Arc eRNAs)
can help RNAPII enter into a productive elongation
stage by facilitating transient release of the nega-
tive elongation factor, NELF, which causes RNAPII
pausing near the TSS.The Role of eRNA Transcript
Several recent studies have suggested that the eRNA transcript
itself might have an activating role in target gene expression in
various cell types (Hsieh et al., 2014; Lam et al., 2013; Li et al.,
2013; Melo et al., 2012; Mousavi et al., 2013; Ilott et al., 2014;
Schaukowitch et al., 2014). Knockdown of eRNAs generated
from various enhancer regions consistently causes a decrease
in the expression of their specific target genes. Multiple mech-
anisms have been described to underlie the eRNA function.
These include the eRNAs regulating enhancer-promoter loop-
ing, chromatin remodeling, and early transcription elongation
(Figure 2). In human MCF-7 breast cancer cells, several eRNAs
expressed from estrogen receptor-a-bound enhancers facilitate
specific enhancer-promoter interactions in a ligand-dependent
manner by recruiting the cohesin complex to the enhancer from
which they originated (Li et al., 2013). An eRNA expressed from
Kallikrein-related peptidase 3 (KLK3) enhancer, one of the
strongest androgen receptor (AR)-bound enhancers in prostate
cancer cells, was also shown to facilitate a specific interaction
between the KLK3 enhancer and the KLK2 promoter but in this
case by forming a complex with AR and a subunit of the Medi-
ator complex, MED1 (Hsieh et al., 2014). Therefore, chromo-
somal looping between specific set(s) of enhancers and
promoters appears to be a key regulatory step in which both
eRNAs and other activating lncRNAs can commonly act
(Figure 2). By contrast, the eRNA expressed from the MYOD1
core enhancer (CERNA) during the myogenic differentiation of
C2C12 skeletal muscle cells had no impact on the enhancer-
promoter interaction (Mousavi et al., 2013). Instead, CERNA
increased RNAPII occupancy at the promoter region of the
MYOD1 gene and subsequent transcription by promoting chro-
matin accessibility. Although the exact mechanism has not
been defined, the chromatin remodeling activity of CERNA is
reminiscent of the function of HOTTIP (Wang et al., 2011)
(Figure 2).954 Cell 162, August 27, 2015 ª2015 Elsevier Inc.Early transcription elongation is another step in which eRNAs
play a role. RNAPII pausing immediately downstream of the tran-
scription start sites is a widespread regulatory mechanism in
higher eukaryotes, which is mediated by negative elongation
factor, NELF, and DRB sensitivity-inducing factor. By serving
as a key rate-limiting step, RNAPII pausing allows the conver-
gence of signaling pathways and is thought to be important for
the establishment of permissible chromatin structure as well as
rapid and/or synchronous gene expression (Adelman and Lis,
2012). During induction of neuronal immediate early genes,
eRNAs contribute to the gene induction in cis by promoting effi-
cient release of NELF from their target gene promoters. eRNAs
are rapidly transcribed and destabilize NELF’s association with
paused RNAPII by directly binding to the RNA recognition motif
present in the NELF-E subunit (Schaukowitch et al., 2014).
Knockdown of eRNA blocks transient release of NELF from
the promoter during transcription activation and specifically de-
creases the amount of elongating RNAPII without affecting the
RNAPII recruitment step or chromosomal looping between the
enhancer and the promoter (Figure 2).
lncRNAs with Enhancer-like Functions
In parallel with the eRNA studies, an independent study discov-
ered an enhancer-like function for a set of long non-coding
RNAs (lncRNAs) in human cell lines, termed ncRNA-activating
(ncRNA-a) (Lai et al., 2013; Ørom et al., 2010). Knockdown of
several lncRNAs in this class invariably reducedexpression levels
of nearby protein coding genes. A subsequentmechanistic study
revealed that the ncRNA-a recruits a transcription coactivator
complex, Mediator, to facilitate chromosomal interaction be-
tween the ncRNA-a loci and its targets (Figure 2) (Lai et al.,
2013). Mediator forms a complex with cohesin that creates a
ring-like structure to keep two DNA segments together, which
then regulates gene expression by connecting the enhancers
and promoters of active genes in a cell-type-specific manner
(Kagey et al., 2010). In parallel, ncRNA-a stimulates the CDK8 ki-
nase activity ofMediator to increase the level of histone H3 phos-
phorylation at serine 10 (H3S10), which is amark associated with
active chromatin and gene induction (Nowak and Corces, 2004).
Other lncRNAs also show related functions in different biolog-
ical contexts. A Notch-regulated lncRNA, LUNAR1 (leukemia-
induced noncoding activator RNA), enhances IGF1R mRNA
expression by a mechanism similar to ncRNA-a (Trimarchi
et al., 2014). Importantly, the enhancer-like activity of LUNAR1
for IGF1R expression was critical for the growth of T cell acute
lymphoblastic leukemia cells both in vitro and in vivo. HOTTIP
is a lncRNA expressed from the tip of the HOXA locus that
coordinates the activation of several HOXA genes in vivo
(Wang et al., 2011). Knockdown of HOTTIP specifically de-
creases expression of distally located HOXA genes, but not
the highly homologous HOXD genes, which suggests a cis
mechanism. Unlike ncRNA-a, HOTTIP does not affect the
chromosomal interaction. Instead, chromosomal looping brings
HOTTIP into close proximity to the HOXA gene locus where
HOTTIP promotes histone H3 lysine 4 trimethylation and gene
transcription by recruiting WDR5/MLL methyltransferase com-
plexes. NeST (nettoie Salmonella pas Theiler’s [cleanup Salmo-
nella not Theiler’s]) is another enhancer-like lncRNA that works
together with WDR5 to increase H3K4me3 level at the inter-
feron-g (Ifng) gene in activated T cells. Transgenic overexpres-
sion of NeST was shown to induce IFN-g synthesis in activated
CD8+ T cells, suggesting a possible trans-mechanism to regu-
late its neighboring gene. Interestingly, a recent study found
the previously described lncRNA, ncRNA-a3, mapping to a bi-di-
rectionally transcribed enhancer of the TAL1 gene (Ørom et al.,
2010; Vucicevic et al., 2015). Therefore, it is likely that, as eRNAs
in different human cells are fully cataloged, many of the currently
annotated lncRNAs with enhancer-like function will fall under the
classification of eRNAs (Vucicevic et al., 2015).
Prospects
Transcription activity at enhancers was first hinted by the pro-
moter-like activity (i.e., able to initiate transcription) of the first
viral enhancer, the 72 bp tandem DNA repeats located upstream
of SV40 early gene. Subsequently, several cellular LCRs and en-
hancers were also shown to transcribe ncRNAs. Nonetheless,
transcriptional activity was not regarded as a general feature
of enhancers until the advent of genome-wide studies. It now
seems clear that ncRNA transcription is a signature of function-
ally active enhancers at least in higher metazoans.
As described above, some experimental evidence already
supports the roles of both enhancer transcription and the
eRNA transcript in gene expression. However, we are still far
from fully understanding the functional and biological signifi-
cance of eRNAs, and more thorough studies on eRNA function
and mechanism will be required. For example, the molecular de-
terminants of eRNA function have not been studied, and thus it is
not known whether specific sequences or secondary structures
would be critical for eRNA function. Moreover, although some
studies found that only the sense eRNAs—transcribed in the
same direction with its target mRNA—appear to be sufficient
for the eRNA function (Lam et al., 2013; Li et al., 2013), it is not
clear at this point whether strand-specific functionality is a gen-eral feature of eRNAs. It also needs to be mentioned that all
current functional studies of eRNAs have relied exclusively on
knockdown and/or overexpression approaches in cell culture;
hence, in vivo relevance is yet to be validated. While in vitro
analytical methods offer technical advantages in mechanistic
studies, several recent examples show that the findings from
cell line studies in vitro are not observed or are quite different
in knockout animals (Kohtz, 2014). Therefore, determining
the biological significance of eRNAs in an in vivo context is
imperative.
The functionality question aside, widespread observation of
transcribed enhancers across multiple mammalian cell types
calls for revising the traditional definition of ‘‘promoters’’ as the
DNA regions that allow accurate transcription initiation of
a gene. Similar to a promoter, an enhancer can direct RNA
transcription from a defined site by independent RNAPII tran-
scription machinery assembled with general TFs. Initiation of
bi-directional transcription is another shared feature of transcrip-
tional regulatory elements. Moreover, many of the features of up-
stream anti-sense transcripts mirror those of eRNAs, including
their inherent instability and their enrichment of the tyrosine 1
phosphorylated form of RNAPII.
Importantly, the distinctive characteristic of the promoters is
their ability to direct transcription of a spliced, polyadenylated
transcript. In contrast to the promoter-driven mRNAs, eRNAs
and upstream anti-sense RNAs are shorter in length (a few hun-
dred base pairs up to a few kilobases) and by and large less sta-
ble. In addition, they are commonly subject to early termination
through the action of the Integrator complex, which is consistent
with their lack of 50 splice sites and polyadenylation-dependent
cleavage. However, as far as transcription initiation is con-
cerned, there appears to be very little difference between the
promoter and the enhancer. Indeed, in many examples, en-
hancers may look reminiscent of weak promoters transcribing
low levels of RNAs. Additional studies will certainly be needed
before we can fully understand and define the structural and
functional identities of enhancers and promoters and their inter-
relationship. Nonetheless, the recent unveiling of shared tran-
scriptional architectures between the two regulatory domains
compels us to revise our old ways of thinking and incorporate
new models of transcriptional regulation in eukaryotes.
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